American Bio Medica Co. (OTCMKTS:ABMC)’s share price passed below its 50-day moving average during trading on Friday . The stock has a 50-day moving average of $0.07 and traded as low as $0.06. American Bio Medica shares last traded at $0.06, with a volume of 29,000 shares changing hands.
The firm has a fifty day moving average of $0.07 and a 200-day moving average of $0.07. The firm has a market cap of $1.96 million, a P/E ratio of -3.00 and a beta of 0.73.
American Bio Medica Company Profile (OTCMKTS:ABMC)
American Bio Medica Corporation develops, manufactures, and sells lateral flow immunoassay tests primarily for the immediate detection of drugs in urine and oral fluids at the point of collection. Its drugs detection products in urine include Rapid Drug Screen, a rapid drug test, which detects the presence or absence of 2 to 10 drugs; Rapid ONE product line that consists of single drug tests, each of which tests for the presence or absence of a single drug; RDS InCup, a drug-testing cup that detects the presence or absence of 1 to 12 drugs; Rapid TOX, a drug test in a cassette platform, which detects the presence or absence of 2 to 10 drugs; Rapid TOX Cup II, a drug testing cup that detects the presence or absence of 1 to 14 drugs; and Rapid TOX Cup II (2G), a second generation of the original Rapid TOX Cup II, which consists of a smaller cup with smaller test strip, as well as private labeled versions of Rapid TOX.
Read More: How do investors use RSI to grade stocks?
Receive News & Ratings for American Bio Medica Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for American Bio Medica and related companies with MarketBeat.com's FREE daily email newsletter.